openPR Logo
Press release

Leiber GmbH further invests in R&D

03-11-2016 10:06 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Leiber GmbH

Dr med vet Claudia Westfahl

Dr med vet Claudia Westfahl

Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University of Veterinary Medicine Hannover in 2005 she worked as a scientific employee at the Institute for Animal Nutrition.

Starting her industrial career in 2008 as a nutritionist for several brands in the international FMCG sector, she brings in eight years of expertise in commercial diet formulations for pet, fish & reptiles taking advantage from a solid educational background in animal nutrition, dietetics and science of feedstuffs including QM and regulatory knowledge.

For almost 60 years the company Leiber, based in Bramsche, has been one of the leading manufacturers of speciality yeast products "Made in Germany". Using innovative biotechnological processing techniques, the natural raw material brewers' yeast is converted into high-quality products that are then used in the animal nutrition, foodstuffs, food supplements and biotechnology sectors. With two locations in Germany, as well as additional production facilities in Poland and Russia, Leiber's over 200 dedicated staff manufactures brewers' yeast products and yeast extracts of the highest quality.

Leiber GmbH
Hafenstraße 24
49565 Bramsche
Germany
Phone: +49 (0) 5461 / 9303-0
Fax: +49 (0) 5461 / 9303-29
E-Mail: info@leibergmbh.de
www.leibergmbh.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leiber GmbH further invests in R&D here

News-ID: 325687 • Views: 859

More Releases from Leiber GmbH

Leiber animal nutrition – Gold medal and innovation prize in Poland
This year's visit to the FERMA trade fair was crowned with shining success for Leiber GmbH and its Polish daughter company - Leiber Sp. z. o.o. based in Krosniewice. This year, the animal feed department with its brewers' yeast range was, once again, represented at the fair in Lodz. FERMA is regarded as the international trade fair and platform for producers and breeders of livestock, pork and poultry in Poland.
Leiber YeaFi® – The Yeast Fibre Concept!
Leiber GmbH has expanded its product range in the area of combined yeast products and adjusted their feed to meet current market trends. For more than 60 years now, Leiber has been combining pure brewers’ yeast with functional fibre products such as brewers’ grains, malt sprouts or wheat germ in a manufacturing process they developed themselves to protect the nutritional ingredients in brewers’ yeast. For several years, the demand for
Leiber Subsidiary in Poland receives FSSC 22000 Certification
Leiber Sp. z o.o., the Polish subsidiary of Leiber GmbH, has successfully completed the FSSC 22000 Food Safety System Certification process. FSSC 22000, which is recognised internationally and also by the Global Food Safety Initiative (GFSI), was developed on the basis of the ISO 22000 Standard to define basic requirements for the certification of production processes within the food supply chain. Brewer’s yeast products are manufactured for the foodstuffs and
Leiber GmbH expands international aquaculture business relationship
By signing the distribution contract between Leiber GmbH and the company PHARMAQ AS, headquartered in Norway, Leiber GmbH teams up with a further distribution partner in the growing markets of aquaculture and expands its existing business activities. PHARMAQ AS develops, produces and markets vaccines and health products for the global fish farming industry. Their customers are found in the salmonid, tilapia, pangasius, sea bass and bream segments. “Pharmaq provides an excellent

All 5 Releases